Approval of APIDRA® gives a shot-in-the-arm to treatment of diabetes, especially in countries like the UAE where diabetes prevalence is among the highest in the world.
Sanofi-aventis announced today that the European Commission has approved APIDRA® (insulin glulisine [rDNA origin] injection), a rapid-acting insulin analog for the control of hyperglycemia in adolescents and children (6 years and older) with diabetes.

on a US$10m DNA technology selection project in poultry breeding.
The recently formed alliance between multi-species breeding company Hendrix Genetics (Boxmeer, The Netherlands) and the broiler breeding company Cobb-Vantress, Inc. (Siloam Springs, Arkansas, USA), is to become the first in the world to implement genomic selection in poultry breeding.